Avoro Capital Advisors LLC Amarin Corp Plcuk Transaction History

Avoro Capital Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	BUY	$3.64 - $7.76 $14.6 Million - $31 Million	4,000,000 Added 200.0%	6,000,000 $25.3 Million
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $400,000 - $2.15 Million	100,000 Added 5.26%	2,000,000 $8 Million
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $92.3 Million - $160 Million	-6,620,000 Reduced 77.7%	1,900,000 $40.7 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $14.2 Million - $23.6 Million	1,020,000 Added 13.6%	8,520,000 $129 Million
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $8.14 Million - $10.3 Million	-500,000 Reduced 6.25%	7,500,000 $145 Million
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $30.6 Million - $54.2 Million	2,425,000 Added 43.5%	8,000,000 $166 Million
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $19 Million - $35.2 Million	1,530,000 Added 37.82%	5,575,000 $75.9 Million
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $9.91 Million - $65.8 Million	4,045,000 New	4,045,000 $65.8 Million

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.